CD8+ T cells, another subtype of T cells, play a crucial role in the host response to antitumor immunity through their cytotoxicity effect to kill tumor cells, and they are thought to be an important reason for the success of cancer immunotherapy (Raskov et al., 2021). The gene discussed is CD8A; the disease is neoplasm.